176 related articles for article (PubMed ID: 21226860)
1. Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury.
Sølling C; Christensen AT; Krag S; Frøkiaer J; Wogensen L; Krog J; Tønnesen EK
Acta Anaesthesiol Scand; 2011 Feb; 55(2):185-95. PubMed ID: 21226860
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia.
Sølling C; Christensen AT; Nygaard U; Krag S; Frøkiaer J; Wogensen L; Krog J; Tønnesen EK
Acta Anaesthesiol Scand; 2011 Apr; 55(4):411-21. PubMed ID: 21342148
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of caspase inhibitors on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney.
Chatterjee PK; Todorovic Z; Sivarajah A; Mota-Filipe H; Brown PA; Stewart KN; Cuzzocrea S; Thiemermann C
Eur J Pharmacol; 2004 Oct; 503(1-3):173-83. PubMed ID: 15496312
[TBL] [Abstract][Full Text] [Related]
4. Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury.
Gobe GC; Bennett NC; West M; Colditz P; Brown L; Vesey DA; Johnson DW
Am J Physiol Renal Physiol; 2014 Mar; 306(6):F681-92. PubMed ID: 24402097
[TBL] [Abstract][Full Text] [Related]
5. Renal oxygenation in acute renal ischemia-reperfusion injury.
Abdelkader A; Ho J; Ow CP; Eppel GA; Rajapakse NW; Schlaich MP; Evans RG
Am J Physiol Renal Physiol; 2014 May; 306(9):F1026-38. PubMed ID: 24598805
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin and acute renal failure.
Sharples EJ; Yaqoob MM
Semin Nephrol; 2006 Jul; 26(4):325-31. PubMed ID: 16949472
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion.
Nitescu N; Ricksten SE; Marcussen N; Haraldsson B; Nilsson U; Basu S; Guron G
Nephrol Dial Transplant; 2006 May; 21(5):1240-7. PubMed ID: 16390850
[TBL] [Abstract][Full Text] [Related]
8. Systemic and renal haemodynamic changes in renal schemia/reperfusion injury: impact of erythropoietin.
Hussein AA; Barakat N; Awadalla A; Shokeir AA
Can J Physiol Pharmacol; 2012 Nov; 90(11):1535-43. PubMed ID: 23181281
[TBL] [Abstract][Full Text] [Related]
9. Effects of N-acetyl-L-cysteine on renal haemodynamics and function in early ischaemia-reperfusion injury in rats.
Nitescu N; Grimberg E; Ricksten SE; Guron G
Clin Exp Pharmacol Physiol; 2006; 33(1-2):53-7. PubMed ID: 16445699
[TBL] [Abstract][Full Text] [Related]
10. The effect of K-ATP channel blockage during erythropoietin treatment in renal ischemia-reperfusion injury.
Yazihan N; Ataoglu H; Kavas GO; Akyurek N; Yener B; Aydm C
J Invest Surg; 2008; 21(6):340-7. PubMed ID: 19160144
[TBL] [Abstract][Full Text] [Related]
11. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion.
Joyce M; Kelly C; Winter D; Chen G; Leahy A; Bouchier-Hayes D
J Surg Res; 2001 Nov; 101(1):79-84. PubMed ID: 11676559
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
[TBL] [Abstract][Full Text] [Related]
13. Recovery from ischemic acute kidney injury by spironolactone administration.
Sánchez-Pozos K; Barrera-Chimal J; Garzón-Muvdi J; Pérez-Villalva R; Rodríguez-Romo R; Cruz C; Gamba G; Bobadilla NA
Nephrol Dial Transplant; 2012 Aug; 27(8):3160-9. PubMed ID: 22516623
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat.
Sepodes B; Maio R; Pinto R; Sharples E; Oliveira P; McDonald M; Yaqoob M; Thiemermann C; Mota-Filipe H
Transpl Int; 2006 Nov; 19(11):919-26. PubMed ID: 17018128
[TBL] [Abstract][Full Text] [Related]
15. Exogenous surfactant attenuation of ischemia-reperfusion injury in the lung through alteration of inflammatory and apoptotic factors.
van Putte BP; Cobelens PM; van der Kaaij N; Lachmann B; Kavelaars A; Heijnen CJ; Kesecioglu J
J Thorac Cardiovasc Surg; 2009 Apr; 137(4):824-8. PubMed ID: 19327503
[TBL] [Abstract][Full Text] [Related]
16. [Renal protective effects of erythropoietin on ischemic reperfusion injury].
Moriyama M; Tanaka T; Suzuki K
Hinyokika Kiyo; 2010 Aug; 56(8):473-9. PubMed ID: 20808070
[TBL] [Abstract][Full Text] [Related]
17. Urotensin-II receptor antagonism does not improve renal haemodynamics or function in rats with endotoxin-induced acute kidney injury.
Nitescu N; Grimberg E; Guron G
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1170-5. PubMed ID: 20880186
[TBL] [Abstract][Full Text] [Related]
18. The effect of warm ischemic time on renal function and injury in the isolated hemoperfused kidney.
Harper SJ; Hosgood SA; Waller HL; Yang B; Kay MD; Goncalves I; Nicholson ML
Transplantation; 2008 Aug; 86(3):445-51. PubMed ID: 18698249
[TBL] [Abstract][Full Text] [Related]
19. Theophylline improves early allograft function in rat kidney transplantation.
Grenz A; Baier D; Petroktistis F; Wehrmann M; Köhle C; Schenk M; Sessler M; Gleiter CH; Fandrich F; Osswald H
J Pharmacol Exp Ther; 2006 May; 317(2):473-9. PubMed ID: 16410406
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor ameliorates renal hemodynamic disorder after ischemia/reperfusion.
Nakatani T; Kim T; Uchida J; Kumata N; Kawashima H; Sugimura K
Int J Mol Med; 2002 Aug; 10(2):217-9. PubMed ID: 12119562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
